| Literature DB >> 31474570 |
Miguel Reina-Campos1, Maria T Diaz-Meco1, Jorge Moscat2.
Abstract
Atypical protein kinase C (aPKC) isozymes, PKCλ/ι and PKCζ, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into tumor-promoter or -suppressive functions. Here, we review early and more recent literature to discuss how the different tumor types, and their microenvironments, might account for the selective signaling of each aPKC isotype. This is of clinical relevance because a better understanding of the roles of these kinases is essential for the design of new anti-cancer treatments.Entities:
Keywords: ECT2; Hedgehog; PD-L1; PHGDH; PKCζ; PKCλ/ι; SOX2; atypical PKCs; basal cell carcinoma; cancer; colorectal cancer; immunotherapy; kinase inhibitors; leukemia; lung cancer; metabolism; p62; polarity; prostate cancer; stroma; tumor promoter; tumor suppressor
Mesh:
Substances:
Year: 2019 PMID: 31474570 PMCID: PMC6751000 DOI: 10.1016/j.ccell.2019.07.010
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743